Cosmetic & Topical Peptides: A Research Literature Overview

NOVA Q Research · Research Library

Cosmetic & Topical Peptides: A Research Literature Overview

What the published research examines for GHK-Cu (copper tripeptide-1) and the broader cosmetic-peptide field, from in-vitro collagen studies to controlled human topical trials.

Neutral literature aggregation · Compiled by NOVA Q Research · Updated 2026-07-24 · 11 cited sources
In brief
  • GHK-Cu is a copper carrier peptide with a roughly four-decade literature spanning in-vitro, animal wound models, and a smaller number of human topical studies.
  • The most detailed work is at the cell and animal mechanistic level (collagen, matrix turnover); controlled human topical outcomes are fewer and mixed.
  • Several high-visibility GHK-Cu overviews are reviews by a small set of overlapping authors, and should be weighed as reviews rather than independent trials.
  • Related cosmetic peptides (e.g. palmitoyl pentapeptide / Matrixyl) have their own controlled human topical studies for photoaging-appearance endpoints.

Cosmetic and topical peptide research is usually organized into signal peptides (studied for modulating extracellular-matrix gene expression), carrier peptides (which deliver trace metals such as copper into cells), and enzyme- or neurotransmitter-inhibiting peptides. Most of the published dermatology and cosmetic-science literature sits in fibroblast and keratinocyte cultures, animal wound models, and a smaller set of controlled human topical studies. GHK-Cu is distinctive because it appears in two overlapping streams at once: a long-standing wound-healing and tissue-remodeling literature, and a newer cosmetic-appearance literature.

GHK-Cu (copper tripeptide-1)

Class / mechanism. The copper(II) complex of the naturally occurring human tripeptide glycyl-L-histidyl-L-lysine (GHK), classified in cosmetic science as a copper carrier peptide. Proposed mechanisms, drawn largely from in-vitro and gene-expression work, describe high copper affinity and associations with extracellular-matrix turnover (collagen, glycosaminoglycans, metalloproteinase balance).

The GHK-Cu evidence base is heterogeneous and spans about four decades. The earliest and most numerous studies are in-vitro (fibroblast and keratinocyte cultures) and animal (rodent wound) models examining collagen synthesis, glycosaminoglycan accumulation, and growth-factor expression. A separate, smaller strand of human research is mostly cosmetic/topical or surgical-adjunct (for example post-procedure skin care and diabetic-ulcer treatment), with mixed objective findings.

Several widely cited overview pieces are narrative or gene-data reviews authored by a small number of overlapping investigators, which is worth keeping in view when reading the field. Overall the literature is strongest at the cell and animal mechanistic level and thinner and less consistent at the level of controlled human topical outcomes.

Selected literature

  1. Maquart FX, et al. 1988. "Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu2+." FEBS Lett 238(2):343-346. https://doi.org/10.1016/0014-5793(88)80509-XIn-vitro dose-response study of collagen synthesis in cultured fibroblasts.
  2. Maquart FX, et al. 1993. "In vivo stimulation of connective tissue accumulation by GHK-Cu2+ in rat experimental wounds." J Clin Invest 92(5):2368-2376. PMID 8227353. https://pubmed.ncbi.nlm.nih.gov/8227353/Rat wound-chamber model measuring connective-tissue accumulation (collagen, GAGs, DNA).
  3. Mulder GD, et al. 1994. "Enhanced healing of ulcers in patients with diabetes by topical GHK copper." Wound Repair Regen 2(4):259-269. https://doi.org/10.1046/j.1524-475X.1994.20406.xHuman clinical study of a topical GHK-Cu formulation as an adjunct in diabetic-ulcer management.
  4. Pollard JD, et al. 2005. "Effects of copper tripeptide on growth and growth-factor expression by normal and irradiated fibroblasts." Arch Facial Plast Surg 7(1):27-31. https://doi.org/10.1001/archfaci.7.1.27In-vitro study of fibroblast proliferation and growth-factor expression.
  5. Miller TR, et al. 2006. "Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin." Arch Facial Plast Surg 8(4):252-259. https://doi.org/10.1001/archfaci.8.4.252Controlled human study of healing measures and patient-reported outcomes after laser resurfacing.
  6. Pickart L, Margolina A. 2018. "Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data." Int J Mol Sci 19(7):1987. PMID 29986520. https://pubmed.ncbi.nlm.nih.gov/29986520/Review interpreting gene-expression datasets attributed to GHK across tissue processes.
  7. Pickart L, Margolina A. 2015. "GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration." Biomed Res Int 2015:648108. https://doi.org/10.1155/2015/648108Narrative review compiling proposed cellular pathways and prior GHK/GHK-Cu findings.
Where the evidence is limited. A substantial share of the high-visibility literature consists of reviews and gene-expression interpretation by a small set of overlapping investigators, and many primary studies are in-vitro or animal rather than controlled human trials. Where human topical studies exist, endpoints and results are mixed and sample sizes small, and formulation, concentration, and outcome measures are not standardized across studies.

Related cosmetic-peptide research landscape (context, not products)

Class / mechanism. Included to situate GHK-Cu within its field. These compounds are cited as scientific literature, not as products.

Palmitoyl pentapeptide (pal-KTTKS, commonly branded Matrixyl) is a lipidated derivative of the KTTKS sequence, itself derived from the C-terminal propeptide of type I collagen. The foundational biochemistry described KTTKS influencing extracellular-matrix production in fibroblast culture; the palmitoylated form was developed to improve skin penetration and has been examined in controlled human topical studies for photoaging-appearance endpoints.

Broader dermatology and cosmetic-science reviews catalog the signal, carrier, and enzyme-inhibitor peptide classes (including GHK-Cu and pal-KTTKS) and appraise the general state and limitations of topical-peptide evidence.

Selected literature

  1. Katayama K, et al. 1993. "A pentapeptide from type I procollagen promotes extracellular matrix production." J Biol Chem 268(14):9941-9944. PMID 8486721. https://pubmed.ncbi.nlm.nih.gov/8486721/Original in-vitro characterization of the KTTKS pentapeptide on matrix production in fibroblasts.
  2. Robinson LR, et al. 2005. "Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin." Int J Cosmet Sci 27(3):155-160. PMID 18492182. https://pubmed.ncbi.nlm.nih.gov/18492182/Double-blind placebo-controlled human facial study of topical pal-KTTKS on photoaging endpoints.
  3. Gorouhi F, Maibach HI. 2009. "Role of topical peptides in preventing or treating aged skin." Int J Cosmet Sci 31(5):327-345. https://doi.org/10.1111/j.1468-2494.2009.00490.xReview categorizing cosmetic peptide classes and appraising the supporting evidence.
  4. Schagen SK. 2017. "Topical peptide treatments with effective anti-aging results." Cosmetics 4(2):16. https://doi.org/10.3390/cosmetics4020016Review of topical anti-aging peptides including copper and palmitoyl peptides.
Where the evidence is limited. Landscape context only; these compounds are not products and are presented to situate the research area.

How to read this report

This report aggregates published scientific literature for the compounds NOVA Q Research supplies in the Cosmetic category. It describes what studies investigated, the models used, and the maturity of the evidence. It does not evaluate, recommend, or imply any use in humans or animals, and it is not medical, veterinary, or research-protocol advice. Where the record is preclinical or geographically concentrated, we say so. Every source is cited so it can be checked independently.

Browse the Cosmetic catalog →
For research use only. Not for human or veterinary use. NOVA Q Research supplies research-grade materials for laboratory research use only. Nothing in this document is intended to diagnose, treat, cure, or prevent any disease, or to guide human or veterinary use. Statements have not been evaluated by the FDA. Citations are provided for reference and do not imply endorsement.